Periodic Reporting for period 3 - TBVAC2020 (TBVAC2020; Advancing novel and promising TB vaccine candidates from discovery to preclinical and early clinical development)

TBVAC2020 built on the highly successful, long-standing collaboration in previous EU FP5-, FP6- and FP7-funded Tuberculosis (TB) vaccine and biomarker R&D projects. Key partners and global leaders in the TB field from Europe, USA, Asia, Africa and Australia were part of the...